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Abstract 
Background: Vibrio parahaemolyticus (V. parahaemolyticus) is a Gram‑negative, halophilic bacterium recognized as 
one of the most important foodborne pathogen. When ingested, V. parahaemolyticus causes a self‑limiting illness 
(Vibriosis), characterized mainly by watery diarrhoea. Treatment is usually oral rehydration and/or antibiotics in com‑
plicated cases. Since 1996, the pathogenic and pandemic V. parahaemolyticus O3:K6 serotype has spread worldwide, 
increasing the reported number of vibriosis cases. Thus, the design of new strategies for pathogen control and illness 
prevention is necessary. Lactobacillus sp. grouped Gram positive innocuous bacteria, part of normal intestinal microbi‑
ota and usually used as oral vaccines for several diarrheic diseases. Recombinants strains of Lactobacillus (RL) express‑
ing pathogen antigens can be used as part of an anti‑adhesion strategy where RL block the pathogen union sites in 
host cells. Thus, we aimed to express MAM‑7 V. parahaemolyticus adhesion protein in Lactobacillus sp. to generate an 
RL that prevents pathogen colonization.
Results: We cloned the MAM‑7 gene from V. parahaemolyticus RIMD 2210633 in Lactobacillus expression vectors. 
Recombinant strains (Lactobacillus rhamnosus pSEC‑MAM7 and L. rhamnosus pCWA‑MAM7) adhered to CaCo‑2 cells 
and competed with the pathogen. However, the L. rhamnosus wild type strain showed the best capacity to inhibit 
pathogen colonization in vitro. In addition, LDH‑assay showed that recombinant strains were cytotoxic compared 
with the wild type isogenic strain.
Conclusions: MAM‑7 expression in lactobacilli reduces the intrinsic inhibitory capacity of L. rhamnosus against V. 
parahaemolyticus.
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Background
Vibrio parahaemolyticus (V. parahaemolyticus) is 
a Gram-negative halophilic bacterium; one of the 
most important foodborne pathogens worldwide. 
Autochthonous to estuarine, marine and coastal environ-
ments, V. parahaemolyticus causes acute gastroenteritis 
by consumption of raw, undercooked and/or mishandled 
seafood [1]. The illness vibriosis is mainly characterized 
by diarrhoea. It is self-limiting and usually treated by 
oral rehydration. In some cases antibiotics are necessary 
[1]. Recently, the CDC reported an increment of 75  % 
in vibriosis cases in the US during 2013, compared with 
the period 2006–2008. During 2010–2013, the incre-
ment observed was 32 %. Considering that the CDC esti-
mates that for every V. parahaemolyticus case reported, 
Open Access
Biological Research
*Correspondence:  annette.trombert@umayor.cl 
†Sebastian Beltran and Cristian A. Munoz‑Bergmann contributed equally 
to this work
2 Present Address: Centro de Genómica y Bioinformática, Facultad 
de Ciencias, Universidad Mayor, Camino La Pirámide 5750, Santiago, 
Huechuraba, Chile
Full list of author information is available at the end of the article
Page 2 of 10Beltran et al. Biol Res  (2016) 49:2 
there are 142 cases not diagnosed, official data are clearly 
underestimated [http://www.cdc.gov/foodnet/data/
trends/trends-2013-progress.html]. In Chile, according 
the Epidemiology Department of the Chilean Ministry of 
Health, during the summer of 2015, there was an increase 
of nearly 56  % of the number of cases in comparison 
with 2014 (Departamento de Epidemiología, Ministerio 
de Salud de Chile, 2015. http://epi.minsal.cl/). Thus, it is 
imperative to design new strategies for the control of this 
pathogen.
Pandemic V. parahaemolyticus O3:K6 strain was first 
detected in Osaka (Japan) in 1950, and since 1996 this 
serotype has been spread throughout India, Europe, 
Africa, North, Central and South America [1]. In addi-
tion to classical V. parahaemolyticus TDH and TRH viru-
lence factors, O3:K6 exhibited specific genetic markers as 
toxRS/New and orf8 [2, 3]. Additionally, V. parahaemo-
lyticus O3:K6 strain RIMD 2210633, was detected for the 
first time in Japan in 1996, encoded for Type 3 secretion 
system (T3SS) and a pathogenicity island (VPaI-7) [4].
In addition, an outer membrane protein, multivalent 
adhesion molecule (MAM) which includes MCE (from 
Mammalian cell entry domains) was recently described 
in V. parahaemolyticus [5, 6]. The protein, named MAM-
7, can mediate pathogen attachment to mammalian cells 
even in the absence of other adhesion proteins [5, 6].
Because adhesion of V. parahaemolyticus to host cellu-
lar membranes is a crucial step for the delivery of patho-
gen toxins, MAM-7 could be considered as a virulence 
factor [7, 8]. Thus, interference with MAM-7-mediated 
adhesion can prevent or treat vibriosis.
Interference with the adhesion of the pathogen is 
known as anti-adhesion therapy (AAT). AAT includes 
disruption of host pathogen receptor biogenesis; ana-
logues to compete with these receptors or antibodies 
block surface epitopes required for pathogen binding [9]. 
The analogues of adhesion can be used purified [10] or 
expressed (secreted or anchored in the outer membrane) 
in non-pathogenic bacteria. Non-pathogenic bacteria 
used for this purpose are those that form part of normal 
microbiota (as non-pathogenic Escherichia coli) or ben-
eficial bacteria (probiotics) as members of acid lactic bac-
teria (i.e. Lactobacillus sp.).
Lactobacillus sp. are generally recognized as safe 
(GRAS), and can colonize human intestinal mucosa. In 
addition, Lactobacillus strains can produce inhibitory 
compounds such as organic acids, hydrogen peroxide 
and bacteriocins that have antimicrobial properties. For 
example, L. plantarum AS1 show antibacterial activ-
ity against several enteropathogens and inhibit V. para-
haemolyticus adhesion to the human intestinal cell line 
HT-29 [11]. Additionally, mice treated with L. rhamnosus 
and L. brevis showed a significant reduction in intestinal 
fluid accumulation and villi damage when animals were 
challenged with the pathogen [12].
Given these characteristics, Lactobacillus strains are 
good candidates for mucosal vaccines and/or therapeu-
tic delivery vehicles. In fact, recombinant lactobacilli 
expressing pathogen antigens can elicit mixed Th1/Th2 
immune responses; induce specific antibodies, dendritic 
cell maturation and production of pro-inflammatory 
cytokines [13]. The most common strategy to gener-
ate recombinant lactobacilli is the cloning of a deter-
mined antigen-encoded gene in expression vectors [12]. 
One example is the use of expression vectors pSEC 
and pCWA to target heterologous proteins to differ-
ent secreted or cell wall destinations in Lactococcus and 
Lactobacillus [14–16]. pSEC harbours a transcriptional 
fusion between the ribosome-binding site (RBSUsp45) and 
the signal peptide sequence (SPUsp45) of the usp45 gene, 
allowing antigen release into the medium. In addition, 
pCWA encoded for Streptococcus pyogenes M6 protein 
cell wall-anchor region CWAM6 [14–18].
We evaluated the role of recombinant Lactobacillus 
strains containing pSEC-MAM7 and pCWA-MAM7 
in the adhesion to human epithelial cell lines and their 
capacity to inhibit V. parahaemolyticus colonization 
in vitro.
Our results showed that L. rhamnosus wild type can 
inhibit and compete in a significantly more efficient man-
ner than both the recombinant strains pSEC-MAM7 and 
pCWA-MAM7. In addition, these recombinant strains 
showed a significantly higher grade of cytotoxicity than 
the L. rhamnosus wild type. Thus, MAM-7 expression 
in lactobacilli does not improve the intrinsic inhibitory 
capacity of L. rhamnosus against V. parahaemolyticus.
Results
Recombinant L. rhamnosus strains
Primers were design from V. parahaemolyticus reported 
sequence RIMD 2210633 (GenBank: NC_004603). The 
PCR product of approx 2600 pb were cloned in pSEC and 
pCWA and used to transform L. rhamnosus. PCR was 
used to check the presence of MAM-7 gene in recombi-
nant L. rhamnosus strains. To check if MAM-7 gene was 
transcribed, we performed an RT-PCR (Fig. 1). Figure 1 
shows the amplicon of MAM-7 gene (Fig. 1a) and ampli-
fication of MAM-7 transcript (Fig. 1b) in both L. rham-
nosus pSEC-MAM7 and L. rhamnosus pCWA-MAM7 
strains.
To assess if MAM-7 protein was expressed in both L. 
rhamnosus pSEC-MAM7 and L. rhamnosus pCWA-
MAM7 strains, we performed an SDS-PAGE (Fig.  2) 
where it was expected a MAM-7 protein size of about 
97  kDa. Figure  2 shows a weak band that corresponds 
to a protein of about 100 kDa (black arrows) suggesting 
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the presence of MAM-7 in L. rhamnosus pSEC-MAM7 
and L. rhamnosus pCWA-MAM7 strains. Thus, to check 
the presence of MAM-7 protein in recombinants strains, 
an immunodetection assay using anti-Vibrio (KPL) and 
anti-rabbit fluorescent (Molecular Probes, Thermo Fisher 
Scientific) antibodies was performed (Fig.  3). Figure  3 
shows that while in L. rhamnosus wild type did not show 
fluorescence, both L. rhamnosus pSEC-MAM7 and 
L. rhamnosus pCWA-MAM7 strains showed fluores-
cent bacteria. The previous results strongly suggest that 
recombinant bacterial strains were expressing V. para-
haemolyticus MAM-7 protein. 
To assess if the expression of MAM-7 alters (or not) 
both L. rhamnosus pSEC-MAM7 and L. rhamnosus 
pCWA-MAM7 growth, a growth curve at 37  ℃ was 
performed (Fig.  4a). As shown in Fig.  4a, growth of 
recombinant strains was not negatively altered with the 
expression of MAM-7 compared with the wild type.
Adherent bacteria, such as L. rhamnosus, can colonize 
different environments as biofilms, where a self-produced 
extracellular matrix protects bacteria against environ-
mental conditions [19]. Biofilm formation can be altered 
by the expression of the MAM-7 protein in L. rhamno-
sus recombinants strains. Therefore, we evaluated the 
biofilm formation capacity of L. rhamnosus recombinant 
and wild type strains using crystal violet staining proto-
col (Fig. 4b). Figure 4b not shows significant differences 
between recombinant and wild type strains. Hence, 
MAM-7 expression did not alter the intrinsic capacity of 
L. rhamnosus to form biofilm.
Adhesion of recombinants L. rhamnosus strains 
to epithelial cell lines
MAM-7 is an outer membrane protein involved in host 
cell early adhesion in Gram negative pathogens includ-
ing V. parahaemolyticus [6]. Thus, our objective was 
to determine if the expression of MAM-7 from RIMD 
in L. rhamnosus promotes bacterial adhesion to both 
human epithelial cell lines CaCo-2 and HEp-2 (Fig. 5a). 
As shown in Fig.  5a, MAM-7 did not promote higher 
adhesion in recombinant L. rhamnosus strains than 
the L. rhamnosus wild type. Furthermore, L. rhamno-
sus pSEC-MAM7 (pSEC-MAM7) showed significantly 
lesser adhesion than L. rhamnosus pCWA-MAM7 
(pCWA-MAM7) and the L. rhamnosus wild type. In 
addition, all L. rhamnosus strains (recombinants and 
wild type strains) were significantly more adhesive than 
RIMD.
Fig. 1 PCR and RT‑PCR of MAM‑7 from recombinants L. rhamno-
sus strains. a PCR of MAM‑7 gene from L. rhamnosus pSEC‑MAM‑7 
(pSEC‑MAM7) and L. rhamnosus pCWA‑MAM‑7 (pCWA‑MAM7) strains. 
b RT‑PCR of MAM‑7 transcript from L. rhamnosus pSEC‑MAM‑7 (pSEC‑
MAM7), L. rhamnosus pCWA‑MAM‑7 (pCWA‑MAM7) and L. rhamnosus 
wild type (L. rhamnosus) strains
Fig. 2 SDS‑PAGE electrophoresis from recombinants L. rhamnsus 
strains. The figure shows the protein profile from L. rhamnosus pSEC‑
MAM‑7 (pSEC‑MAM7), L. rhamnosus pCWA‑MAM‑7 (pCWA‑MAM7) 
and L. rhamnosus wild type (L. rhamnosus). Black arrows show a 
weakly band of approximately 100 kDa in recombinants strains. Bands 
of each lane were detected using GelAnalyzer and each white circle 
indicates a band
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Inhibition of V. parahaemolyticus from colonizing HEp‑2 
and CaCo‑2 cell lines
Competition assay: Krachler et  al. demonstrated that E. 
coli BL21 expressing MAM-7 inhibits V. parahaemolyti-
cus attachment in HeLa cells [7, 9]. Thus, we expected 
that recombinant L. rhamnosus strains inhibit V. para-
haemolyticus attachment in HEp-2 and/or CaCo-2 cell 
lines. Figure 5b shows that all L. rhamnosus strains effi-
ciently competed with RIMD in HEp-2 cell line but L. 
rhamnosus wild type inhibition was higher than the 
recombinant strains. In CaCo-2, only L. rhamnosus wild 
type inhibited RIMD adhesion. Hence, L. rhamnosus wild 
type inhibited the adherence of V. parahaemolyticus to 
HEp-2 and Caco-2 cell lines more efficiently than recom-
binants strains.
Exclusion assay: To asses if V. parahaemolyticus could 
adhere to CaCo-2 already colonized with L. rhamno-
sus wild type or recombinant strains, we performed an 
exclusion assay in this cell line (Fig. 6). All L. rhamnosus 
strains significantly excluded RIMD from the CaCo-2 cell 
Fig. 3 Expression of MAM‑7 protein in L. rhamnosus. MAM‑7 protein 
was detected using anti‑Vibrio antibody and revealed with a sec‑
ondary antibody alexa fluor® conjugated. The figures shows green 
fluorescence of alexa fluor® only in recombinant L. rhamnosus strains 
(L. rhamnosus pSEC‑MAM‑7 and L. rhamnosus pCWA‑MAM‑7). As a 
control, L. rhamnosus wild type was used
Fig. 4 Effect of MAM‑7 expression in L. rhamnosus in vitro growth. 
a Growth curve of L. rhamnosus pCWA‑MAM‑7 (black squares), L. 
rhamnosus pSEC‑MAM‑7 (black circles) recombinants strains and L. 
rhamnosus wild type strain (black triangle). b Biofilm formation of L. 
rhamnosus pSEC‑MAM‑7 (black column), L. rhamnosus pCWA‑MAM‑7 
(striped column) recombinants strains and L. rhamnosus wild type 
strain (grey column). White column shows control with sterile MRS 
broth. The figure shows values expressed as the mean ± standard 
deviation of three full biological replicates, each time in technical 
triplicate
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line. However, the L. rhamnosus wild type was signifi-
cantly better than recombinant strains in excluding the 
pathogen. In fact, when RIMD was incubated with CaCo-
2, a 16  % of adhesion was obtained. However, when we 
pre-colonized CaCo-2 with L. rhamnosus wild type, only 
1 % of the adhered pathogen was recovered.
Cytotoxic effect of L. rhamnosus expressing MAM‑7
It has been reported that MAM-7 mediates V. para-
haemolyticus TDH- independent cytotoxicity [6]. Thus, 
we wanted to know if Lactobacillus recombinant strains 
could generate cytotoxicity in CaCo-2 cell lines. Both 
pSEC-MAM7 and pCWA-MAM7 were significantly 
more cytotoxic than L. rhamnosus wild type (Fig.  7). 
However, cytotoxicity levels were significantly lower than 
the positive control. Our results suggest that the presence 
of MAM-7 in L. rhamnosus can induce cytotoxicity in the 
CaCo-2 cell line.
Fig. 5 Adhesion and competition assays of V. parahaemolyticus and 
L. rhamnosus strains in epithelial cell lines. a Adhesion assay. The 
figure shows the adhesion percentage of L. rhamnosus strains and V. 
parahaemolyticus in epithelial cell line (HEp‑2, black bars) and colon 
carcinoma cell line (CaCo‑2, gray bars) monolayers. The strains used 
were V. parahaemolyticus RIMD 2210633 (RIMD), L. rhamnosus wild 
type (L. rhamnosus), L. rhamnosus/pCWA‑MAM‑7 (pCWA‑MAM7) 
and L. rhamnosus/pSEC‑MAM‑7 (pSEC‑MAM7). The results were 
expressed such as the percentage of adhesion at 3 h compared with 
initial inoculums of each strain at time zero. The figure shows values 
expressed as the mean ± standard deviation of three full biological 
replicates, each time in technical triplicate. *p < 0.001 (Student’s‑Test). 
b Competition assay. The figure shows the results about the role 
of L. rhamnosus strains in the inhibition of V. parahaemolyticus from 
colonizing epithelial cell line (HEp‑2, black bars) and colon carcinoma 
cell line (CaCo‑2, gray bars) monolayers. The strains used were V. para-
haemolyticus RIMD 2210633 (RIMD), L. rhamnosus wild type (L. rham-
nosus), L. rhamnosus/pCWA‑MAM‑7 (pCWA‑MAM7) and L. rhamnosus/
pSEC‑MAM‑7 (pSEC‑MAM7). Values expressed as a ration between 
the number of Lactobacillus strains UFC versus V. parahaemolyticus 
UFC after 3 h of monolayers 1:1 co‑infection. The figure represents 
the result of three full biological replicates, each time in technical 
triplicate. The figure shows values expressed as the mean ± standard 
deviation of three full biological replicates, each time in technical 
triplicate. *p < 0.001 (Student’s‑Test)
Fig. 6 Competitive exclusion of L. rhamnosus to protect CaCo‑2 
cell line from V. parahaemolyticus colonization. The figure shows the 
results about the role of L. rhamnosus strains in the inhibition of V. 
parahaemolyticus from colonizing colon carcinoma cell line (CaCo‑2) 
monolayers. The strains used were V. parahaemolyticus RIMD 2210633 
(RIMD), L. rhamnosus wild type (L. rhamnosus), L. rhamnosus pCWA‑
MAM‑7 (pCWA‑MAM7) and L. rhamnosus pSEC‑MAM‑7 (pSEC‑MAM7). 
Values are expressed as the adhesion percentage of V. parahaemolyti-
cus after 3 h of L. rhamnosus wild type (L. rhamnosus– RIMD), pCWA‑
MAM‑7 (pCWA‑MAM7– RIMD) or pSEC‑MAM‑7 (pSEC‑MAM7– RIMD) 
strains monolayer colonization. V. parahaemolyticus adhesion, without 
previous Lactobacillus treatment, is expressed as “Adhesion” bar. The 
figure shows values expressed as the mean ± standard deviation 
of three full biological replicates, each time in technical triplicate. 
*p < 0.001 (Student’s‑Test)
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Discussion
We evaluated the anti-adhesion capacity of L. rhamnosus 
recombinant strains against V. parahaemolyticus com-
pared to the wild type, in HEp-2 and CaCo-2 epithelial 
cell lines.
Adhesion of recombinant L. rhamnosus strains was 
not better than that of L. rhamnosus wild type. In fact, 
in CaCo-2, an epithelial cell line that mimics epithelial 
cells of human colon, recombinant strains adhesion lev-
els were significantly lower. L. rhamnosus are some of 
the most adhesive Lactobacillus species in CaCo-2 and 
HEp-2 cell lines [20, 21] and their adhesive capacity is 
mediated by numerous and varied surface proteins (such 
as S-layers proteins) and other structural molecules that 
form part of their surface architecture [22–24]. However, 
in Gram-negative bacteria, MAM-7 mce domains medi-
ate attachment to host tissues by interaction with host 
fibronectin and membrane lipid phosphatidic acid (PA) 
[6]. Thus, bacteria that have the ability to bind to host 
fibronectin can be inhibited by the presence of MAM-7. 
Such is the case of the Gram-positive pathogen Staphy-
lococcus aureus, which employs adhesins to attach and 
invade host cells through the interaction with fibronec-
tin and can be inhibited by MAM-7 derived peptides [9, 
25]. Recently, it was found that L. rhamnosus possesses 
a mucus-binding factor (MBF) that binds to mucin, 
laminin, collagen and fibronectin [26, 27]. Thus, the pres-
ence of attached or secreted MAM-7 in cell cultures 
could inhibited recombinant L. rhamnosus adhesion 
to epithelial cell lines and/or negatively interfere with 
intrinsic adhesion mechanisms of L. rhamnosus.
In our study, the presence of MAM-7 in L. rhamnosus 
induced cytotoxicity in CaCo-2 cell lines, suggesting that 
V. parahaemolyticus MAM-7 may trigger death in this 
adenocarcinoma cell line. In addition, Lim et  al. dem-
onstrated that V. parahaemolyticus MAM-7 is sufficient 
to disrupt the epithelial barrier and promote cell lysis. 
In HeLa as well as in the CaCo-2 cell line, MAM-7 trig-
gered disruption of the epithelial barrier and a marked 
decreased in transepithelial electrical resistance (TER) 
[28].
V. parahaemolyticus MAM-7 recognizes host mem-
brane PA lipids and can cluster on cell surface trigger-
ing the activation of the small GTPase RhoA [28]. In the 
same way, activation of Rho-associated serine/threo-
nine kinase (ROCK) was observed downstream RhoA 
[28]. ROCK protein signalling can acts both a pro- and 
anti-apoptotic fashion depends of cell type, cell context 
and microenvironment [29]. ROCK family contains two 
members: ROCK1 and ROCK2 [30]. ROCK1 is related 
with cellular blebbing and blebbing is a conserved event 
of the apoptotic execution phase [29, 31]. Given that 
release of lactate dehydrogenase is related with either 
apoptosis or necrosis events, the level of LDH activity 
as a result of MAM-7 expression in L. rhamnosus could 
be related with apoptotic processes related with ROCK 
activation. Although there are a number of studies of 
pro-survival role of ROCK, ROCK proteins are essential 
for multiple aspects of both the intrinsic and extrinsic 
apoptotic processes [29]. The molecular mechanisms that 
modulate these pleiotropic roles are largely unknown. 
Thus, Lactobacillus expression of MAM-7 could have a 
role inducing apoptosis in CaCo-2 carcinoma cell line.
Conclusion
L. rhamnosus can inhibit adhesion of V. parahaemolyti-
cus in human epithelial cell lines. Expression of V. para-
haemolyticus MAM-7 adhesin in L. rhamnosus decreases 
the intrinsic capacities of L. rhamnosus to inhibit V. para-
haemolyticus in vitro.
Methods
Bacterial strains and culture conditions
V. parahaemolyticus (RIMD 2210633) serotype O3:K6 
was obtained from Instituto de Salud Pública, (ISP, 
Chile). The strain was routinely grown in Luria–Ber-
tani broth supplemented with 1,5 % NaCl (LBS) (Merck) 
and cultured with agitation at 37  ℃ for 12–24  h. L. 
Fig. 7 Cytotoxicity of V. parahaemolyticus and recombinants L. rham-
nosus strains in CaCo‑2 cell line. The figure shows LDH level release as 
absorbance at 490 nm of V. parahaemolyticus and Lactobacillus strains 
in colon carcinoma cell line (CaCo‑2) monolayers. The strains used 
were V. parahaemolyticus RIMD 2210633 (RIMD), L. rhamnosus wild 
type (L. rhamnosus), L. rhamnosus pCWA‑MAM‑7 (pCWA‑MAM7) and 
L. rhamnosus pSEC‑MAM‑7 (pSEC‑MAM7). As a positive control (Con‑
trol+), CaCo‑2 were treated with Tritón  ×100. The figure represents 
the result of three full biological replicates, each time in technical 
triplicate. *p < 0.001 (Student’s‑Test)
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rhamnosus LL1 was previously isolated from fermented 
dairy food, and was grown in de Man Rogosa and Sharpe 
broth (MRS, Merck) at 5–10 % CO2 (capnophilically) and 
at 37 ℃ without agitation for 48 h.
L. rhamnosus recombinants strains
The MAM-7 gene was amplified from genomic DNA from 
V. parahaemolyticus using the primers MAM7-F (CCGA 
TATC TCCGTATGTG CC TGATGTTAAGAG GA) 
and MAM7-R (CCAATGCATCAAGGGCTTAGGAAT 
TGGCGTT) designed from V. parahaemolyticus 
reported sequence RIMD 2210633 (GenBank: NC_ 
004603.1). PCR amplification was performed using 1.25 
U of Dream Taq® (Fermentas), 40  ng of genomic DNA 
from RIMD, and 65  ℃ of annealing temperature (30 
cycles). The amplification product was cloned in pSEC 
and pCWA plasmids at EcoRV and NsiI restriction sites 
to yield the plasmids pSEC-MAM7 and pCWA-MAM7. 
Resulting recombinant vectors were used to transform 
L. rhamnosus according to Serror et al. [32]. Presence of 
MAM-7 gene in L. rhamnosus strains was confirmed by 
PCR amplification and restriction endonuclease analyses. 
Expression of MAM-7 from each plasmid was assessed 
by RT-PCR using primers MAMRT-F (GCTCTACCT 
GACGACAACAAAGT) and MAMRT-R (TTCCTATCG 
GTGCGGTCTAC) (Fig.  1) and Western blot (Data not 
shown).
Protein extraction
40  mL of MRS cultures of each recombinant L. rham-
nosus and wild type strains was centrifuged at top speed 
for 2 min and washed once with PBS 1X (Gibco). Bacte-
rial pellets were resuspended in digestion buffer (50 mM 
Tris–HCL pH 8,0; 5 mM MgCl2; 50 mM EDTA; 10 mg/
mL lysozyme) and incubated by 3 h at 37 ℃. Glass pearls 
were then added and lysates were vortexed for 120  s. 
Then, the lysates were centrifuged at 7000xg for 15 min. 
Supernatants were recovered and sonicated in ice three 
times for 10 s each. Proteins were precipitated with 10 % 
trichloroacetic acid (TCA, Merck) for 12 h and then cen-
trifuged at top speed at 4 ℃ for 20  min. Supernatants 
were discarded, and pellets were washed once with cold 
acetone and centrifuged at top speed at 4 ℃ for 5  min. 
Obtained pellets were resuspended with buffer (100 mM 
Tris–HCl pH 8,0) and stored at −20 ℃ until their use.
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS‑PAGE)
To evaluate the presence of MAM-7 protein, a SDS-
PAGE was performed. A polyacrylamide gel (with 10  % 
acrylamide in separating gel) was prepared according 
to standard protocol. 50  μg of each protein sample was 
loaded and gel was run in a Mini-PROTEAN chamber 
at 100  V for 2  h (BioRad) in pH 8,3 Tris-glicine-SDS 
buffer. The gel was stained with silver using the Pierce 
Silver Stain Kit (Thermo Fisher Scientific) according the 
instruction of manufacturer. Gel electrophoresis bands 
were analyzed using freeware 1D gel electrophoresis 
image analysis software GelAnalyzer (http://www.gelana-
lyzer.com/index.html).
Fluorescent immunodetection assay
To asses if recombinant L. rhamnosus strains expressed 
MAM-7, bacterial samples were placed onto coverslips 
previously treated with poly-l-lysine (Sigma) for 20 min 
at room temperature. Each coverslip with the sample was 
dried at 37 ℃ and fixed with 3 % paraformaldehyde (PFA, 
Merck) for 15 min at room temperature. Then, coverslips 
were put on 24-well cell culture plate (TrueLine) and 
washed three times with PBS 1 × (Gibco). Samples were 
then blocked using 1  % albumin bovine serum (BSA, 
Calbiochem®) for 1  h at room temperature in humid-
ity chamber. Each sample was incubated with 50  μL of 
1:50 anti-Vibrio primary antibody (BacTrace anti-vibrio 
species antibody, KPL) for 12  h at 4 ℃. Once time had 
passed, each sample was washed with PBS 1 ×  (Gibco) 
and then, incubated with 50 μL of 1:500 goat anti-rabbit 
secondary antibody alexa fluor® 488 conjugate (molecu-
lar probes) in darkness and humidity chamber for 2  h. 
After that, samples were washed three times with PBS 
(Gibco) and coversilps were mounted over microscope 
slides with Dako fluorescent mounting medium (Fluo-
romont-g Emsdiasum) for 1 h in darkness. Image adqui-
sition was performed in Leica TCS SP8, DMI6000 CS 
(Leica Microsystems). Adquisition was performed with 
argon laser, HC PL APO CS2 63x/1.40 oil objective, and 
optic slices were set at 0.895 μm.
Growth curves
To assess if MAM-7 expression alters the growth of L. 
rhamnosus recombinants strains, Lactobacillus strains 
were cultivated in MRS broth (wild type), or MRS sup-
plemented with chloramphenicol (recombinants strains) 
at 5–10 % CO2 at 37 ℃. Then, an aliquot of each culture 
was aseptically obtained at 0, 2, 17, 26 and 45 h and seri-
ally diluted in MRS. The bacterial concentration was 
determined according the number of CFU/mL of MRS. 
The assay was performed in triplicate.
Biofilm formation
To assess if MAM-7 expression alters intrinsic proper-
ties of Lactobacillus as biofilm formation, wild type and 
recombinant Lactobacillus strains were cultivated in 
MRS broth (wild type), or MRS supplemented with chlo-
ramphenicol (recombinants strains) at 5–10  % CO2 at 
37 ℃ for 24 h. After the time, optical density at 600 nm 
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(OD600nm) was measured. A volume of 100 μL of bacte-
rial cultures adjusted at OD600nm 0, 2 were used to inocu-
late sterile 96-well plates (TrueLine) (108 cells/well) and 
grown at 5–10  % CO2 at 37 ℃ for 5  days. Sterile MRS 
broth was used as a control.
Crystal violet staining
To assess biofilm formation, crystal violet staining pro-
tocol was used. Cells suspensions were removed from 
test wells before washing three times with PBS. 100  μL 
of methanol (Winkler) was added to each test well and 
was incubated for 15 min at room temperature. After this 
treatment, methanol was discarded before drying. 100 μL 
of 2 % (w/v) crystal violet solution was added and wells 
were further incubated at room temperature for 5  min. 
After this incubation, the non-bound dye was removed 
and wells were washed with H2O. Bound crystal vio-
let was dissolved using 33  % (v/v) of glacial acetic acid 
(Winkler). The resulting dissolved dye was measured at 
a wavelength of 590 nm using NanoQuant Infinite M200 
PRO (TECAN).
Adhesion assay
To assess bacterial adhesion to epithelial cells, both 
HEp-2 and CaCo-2 cell lines were grown in 96-well plates 
(TrueLine) (105 cells/well) at 37 ℃ with 5 % CO2/95 % air 
atmosphere in DMEM High Glucose (HyClone). V. para-
haemolyticus RIMD were grown overnight in LBS, while 
L. rhamnosus wild type and recombinant strains were 
grown overnight in a capnophilic environment in MRS 
broth (wild type), or MRS supplemented with chloram-
phenicol (recombinants strains) at 37 ℃. Bacterial cultures 
were harvested by centrifugation prior to colonisation 
of the cellular monolayers (approx. 108 UFC/mL of each 
strain). After 3 h of co-incubation at 37 ℃ in 5 % CO2 to 
allow bacteria to adhere to eukaryotic cells, monolayers 
were washed twice with phosphate-buffered saline (PBS, 
Gibco). Cells were then lysed with Tritón X-100 (1 %, in 
PBS), and the quantity of bacteria was determined. Quan-
titative adhesion assay values were calculated as follows:
% Adhesion =  100 × [(UFC mL−1 at 3 h post-coloni-
zation)/(UFC mL−1 added)]. The output is the result of 
three independent assays and each experiment was made 
in triplicate.
Competition assay
In this assay, L. rhamnosus strains (108 CFU/mL) and V. 
parahaemolyticus (108 CFU/mL) were added simultane-
ously to CaCo-2 and HEp-2 cell lines. The strains were 
then co-incubated for 3 h at 37 ℃ with 5 % CO2/95 % air 
atmosphere. After the incubation period, non-adhered 
bacteria were removed by washing with PBS, and adhered 
bacterial cells were recovered by lysis of eukaryotic cells 
with Tritón X-100 (1  %, in PBS). Bacterial count was 
expressed as: Ratio = [(UCF mL−1 L. rhamnosus strain)/
(UFC mL−1 V. parahaemolyticus)] at 3  h. The output is 
the result of three independent assays and each experi-
ment was made in triplicate.
Exclusion assay
For exclusion assays, approximately 108 CFU/mL of 
Lactobacillus strains (wild type or recombinant strains) 
were added to confluent CaCo-2 monolayers in 96-well 
plates, in presence of 5  % CO2/95  % air atmosphere at 
37 ℃. After 3 h of co-incubation to allow bacteria adhere 
to eukaryotic cells, monolayers were washed twice with 
PBS (Gibco) to remove non-adhered bacteria. Then, 108 
CFU/mL of V. parahaemolyticus was added to CaCo-2 
already colonized by L. rhamnosus strains, which allowed 
further incubation of 3  h in presence of 5  % CO2/95  % 
air atmosphere at 37 ℃. After the co-incubation period, 
non-adhered bacteria were removed by washing with 
PBS, and bacteria were recovered by lysis of eukaryotic 
cells with Tritón X-100 (1  %, in PBS). Bacterial counts 
were expressed as percentage of adhered V. parahaemo-
lyticus, as mentioned earlier. The output is the result of 
three independent assays and each experiment was made 
in triplicate.
LDH cytotoxicity assay
To assess if the expression of MAM-7 in L. rhamno-
sus can induce cytotoxicity in CaCo-2 cells, an LDH-
Cytotxicity assay was performed. V. parahaemolyticus 
RIMD were grown overnight in LBS, while L. rhamno-
sus wild type and recombinant strains were grown over-
night in a capnophilic environment in MRS broth (wild 
type), or MRS supplemented with chloramphenicol 
(recombinants strains) at 37 ℃. Bacterial cultures were 
harvested by centrifugation prior to colonisation of the 
cellular monolayers (approx. 108 UFC/mL of each strain). 
After 4 h supernatants from CaCo-2 cells colonized by V. 
parahaemolyticus or L. rhamnosus strains was assayed 
using the Cyto Tox® NonRadiactive cytotoxicity assay 
(Promega), which measures the extracellular release of 
LDH into media by dead cells, according manufacturer’s 
instructions. As a positive control, CaCo-2 were treated 
with Tritón X-100 for 45 min.
The absorbance values of treated cells were expressed 
at 490  nm after correcting for background from media 
without cells. The output is the result of three inde-
pendent assays, and each experiment was carried out in 
triplicate.
Statistics
Results are expressed as average  ±  SD of an indi-
vidual experiment performed in triplicate. P values 
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were calculated according to Student’s t test, and val-
ues p  <  0.05 or p  <  0.01 were considered statistically 
significant.
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